Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (Q6)Dec 31, 2024 | (FY)Jun 30, 2024 | (Q6)Dec 31, 2023 | (FY)Jun 30, 2023 | (Q6)Dec 31, 2022 | (FY)Jun 30, 2022 | (Q6)Dec 31, 2021 | (FY)Jun 30, 2021 | (Q6)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -124.04%-101.91M | ---- | -8,523.52%-45.49M | ---- | 118.14%540K | ---- | 77.96%-2.98M | ---- | 82.86%-13.51M | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | -38.71%-430K | ---- | -86.75%-310K | ---- | -14.48%-166K | ---- | 77.62%-145K | ---- | -980.00%-648K | ---- |
| Dividend (income)- adjustment | 0.00%-3M | ---- | 0.00%-3M | ---- | 0.00%-3M | ---- | 0.00%-3M | ---- | 28.30%-3M | ---- |
| Impairment and provisions: | 134.65%82.97M | ---- | 887.16%35.36M | ---- | -79.09%3.58M | ---- | -23.32%17.13M | ---- | -61.83%22.34M | ---- |
| -Impairment of property, plant and equipment (reversal) | 748.17%38.7M | ---- | 59.02%-5.97M | ---- | -294.59%-14.57M | ---- | -64.77%7.49M | ---- | -67.28%21.25M | ---- |
| -Impairment of trade receivables (reversal) | 870.45%427K | ---- | -85.76%44K | ---- | -63.04%309K | ---- | 27,966.67%836K | ---- | 99.96%-3K | ---- |
| -Other impairments and provisions | 6.21%43.85M | ---- | 131.40%41.29M | ---- | 102.61%17.84M | ---- | 709.38%8.81M | ---- | 175.82%1.09M | ---- |
| Revaluation surplus: | 34.88%36.99M | ---- | 450.22%27.42M | ---- | -28.43%4.98M | ---- | 1,281.75%6.96M | ---- | -96.16%504K | ---- |
| -Fair value of investment properties (increase) | 35.76%37.24M | ---- | 450.30%27.43M | ---- | -28.43%4.98M | ---- | 1,292.80%6.96M | ---- | -96.15%500K | ---- |
| -Other fair value changes | -6,075.00%-247K | ---- | ---4K | ---- | ---- | ---- | ---- | ---- | -96.40%4K | ---- |
| Asset sale loss (gain): | -20,227.27%-2.21M | ---- | --11K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) from sale of subsidiary company | ---2.21M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | --11K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | 6.71%23.12M | ---- | 6.70%21.67M | ---- | -0.03%20.31M | ---- | -1.54%20.32M | ---- | -56.26%20.63M | ---- |
| -Depreciation | 6.71%23.12M | ---- | 6.70%21.67M | ---- | -0.03%20.31M | ---- | -1.54%20.32M | ---- | -11.78%20.63M | ---- |
| Financial expense | -9.06%12.38M | ---- | 97.15%13.61M | ---- | 33.04%6.91M | ---- | --5.19M | ---- | ---- | ---- |
| Special items | --5.61M | ---- | ---- | ---- | ---- | ---- | -972,800.00%-29.18M | ---- | --3K | ---- |
| Operating profit before the change of operating capital | 8.61%53.52M | ---- | 48.64%49.28M | ---- | 131.92%33.15M | ---- | -45.69%14.3M | ---- | -26.79%26.32M | ---- |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | 104.60%242K | ---- | -373.49%-5.26M | ---- | 130.21%1.92M | ---- | -41.69%-6.37M | ---- | -121.97%-4.5M | ---- |
| Accounts payable increase (decrease) | 190.78%4.04M | ---- | -57.26%1.39M | ---- | 254.84%3.25M | ---- | -265.68%-2.1M | ---- | -149.65%-574K | ---- |
| Special items for working capital changes | 99.91%-99K | ---- | 15.33%-116.03M | ---- | -67.32%-137.04M | ---- | -126.46%-81.9M | ---- | 390.09%309.57M | ---- |
| Cash from business operations | 181.70%57.71M | ---- | 28.45%-70.63M | ---- | -29.76%-98.72M | ---- | -123.00%-76.08M | ---- | 773.05%330.82M | ---- |
| Other taxs | -47.68%-5.36M | ---- | -106.72%-3.63M | ---- | 76.27%-1.76M | ---- | -8.46%-7.4M | ---- | -24.89%-6.82M | ---- |
| Special items of business | ---- | 176.09%24.55M | ---- | 52.91%-32.26M | ---- | -421.64%-68.52M | ---- | -112.08%-13.14M | ---- | 92.07%108.75M |
| Net cash from operations | 170.49%52.35M | 176.09%24.55M | 26.09%-74.26M | 52.91%-32.26M | -20.37%-100.47M | -421.64%-68.52M | -125.76%-83.47M | -112.08%-13.14M | 693.29%324.01M | 92.07%108.75M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 38.71%430K | ---- | 86.75%310K | ---- | 14.48%166K | ---- | -77.62%145K | ---- | 980.00%648K | ---- |
| Dividend received - investment | 0.00%3M | ---- | 0.00%3M | ---- | 0.00%3M | ---- | 0.00%3M | ---- | -28.30%3M | ---- |
| Sale of fixed assets | ---- | ---- | 4,700.00%48K | ---- | --1K | ---- | ---- | ---- | ---- | ---- |
| Purchase of fixed assets | -75.96%-3.86M | ---- | -35.56%-2.2M | ---- | -243.95%-1.62M | ---- | 5.23%-471K | ---- | -688.89%-497K | ---- |
| Purchase of intangible assets | ---- | ---- | -133.52%-411K | ---- | 71.84%-176K | ---- | ---625K | ---- | ---- | ---- |
| Sale of subsidiaries | --40.78M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---34.63M | ---- | ---- | ---- |
| Recovery of cash from investments | --1.1M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items in the investment business | ---- | 105.69%1.48M | ---- | -24.29%720K | ---- | 102.69%951K | ---- | -2,460.87%-35.3M | ---- | -93.64%1.5M |
| Net cash from investment operations | 5,418.64%41.45M | 105.69%1.48M | -45.22%751K | -24.29%720K | 104.21%1.37M | 102.69%951K | -1,133.83%-32.58M | -2,460.87%-35.3M | -87.41%3.15M | -93.64%1.5M |
| Net cash before financing | 227.60%93.79M | 182.52%26.03M | 25.83%-73.51M | 53.32%-31.54M | 14.60%-99.1M | -39.51%-67.57M | -135.47%-116.05M | -143.93%-48.43M | 1,205.52%327.16M | 37.58%110.24M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 38.46%162.55M | ---- | 130.42%117.4M | ---- | 215.48%50.95M | ---- | --16.15M | ---- | ---- | ---- |
| Refund | -912.74%-214.7M | ---- | -278.57%-21.2M | ---- | 97.66%-5.6M | ---- | ---239.8M | ---- | ---- | ---- |
| Interest paid - financing | -46.55%-10.25M | ---- | -1,046.23%-6.99M | ---- | 58.05%-610K | ---- | ---1.45M | ---- | ---- | ---- |
| Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 41.69%-23.55M | ---- |
| Other items of the financing business | ---32.62M | -144.78%-29.74M | ---- | 33,099.50%66.4M | ---- | 100.09%200K | ---- | -890.45%-233.25M | ---- | 41.68%-23.55M |
| Net cash from financing operations | -212.14%-98.83M | -144.78%-29.74M | 99.02%88.13M | 33,099.50%66.4M | 119.67%44.28M | 100.09%200K | -855.84%-225.1M | -890.45%-233.25M | -122.34%-23.55M | 41.68%-23.55M |
| Effect of rate | 345.27%1.22M | -195.48%-591K | 86.09%-497K | -93.10%619K | -274.42%-3.57M | 1,096.89%8.97M | ---954K | ---900K | ---- | ---- |
| Net Cash | -134.47%-5.04M | -110.63%-3.71M | 126.68%14.62M | 151.74%34.86M | 83.93%-54.82M | 76.08%-67.37M | -212.36%-341.15M | -424.91%-281.68M | 300.35%303.61M | 118.11%86.69M |
| Begining period cash | 22.38%77.24M | 22.38%77.24M | -48.06%63.11M | -48.06%63.11M | -73.79%121.5M | -73.79%121.5M | 189.76%463.6M | 189.76%463.6M | 90.11%160M | 90.11%160M |
| Items Period | ---- | ---9.57M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash at the end | -4.95%73.42M | -35.72%63.37M | 22.38%77.24M | 56.22%98.59M | -48.06%63.11M | -65.14%63.11M | -73.79%121.5M | -26.62%181.02M | 189.76%463.6M | 99.09%246.69M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Rosenmei Certified Public Accountants | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.